Azzad Asset Management’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $872K | Buy |
13,881
+419
| +3% | +$29.2K | 0.09% | 243 |
|
|
2025
Q4 | $893K | Buy |
13,462
+263
| +2% | +$17K | 0.09% | 246 |
|
|
2025
Q3 | $888K | Buy |
13,199
+8,905
| +207% | +$705K | 0.09% | 250 |
|
|
2025
Q2 | $375K | Hold |
4,294
| – | – | 0.04% | 283 |
|
|
2025
Q1 | $293K | Buy |
+4,294
| New | +$350K | 0.03% | 287 |
|
|
2024
Q4 | – | Sell |
-42,994
| Closed | -$2.88M | – | 199 |
|
|
2024
Q3 | $2.88M | Sell |
42,994
-1,992
| -4% | -$164K | 0.32% | 113 |
|
|
2024
Q2 | $5.1M | Buy |
44,986
+2
| +0% | +$253 | 0.6% | 26 |
|
|
2024
Q1 | $6.24M | Sell |
44,984
-3
| -0% | -$377 | 0.73% | 21 |
|
|
2023
Q4 | $5.58M | Buy |
44,987
+25
| +0.1% | +$2.55K | 0.71% | 21 |
|
|
2023
Q3 | $4.19M | Buy |
44,962
+20
| +0% | +$2.25K | 0.59% | 37 |
|
|
2023
Q2 | $5.78M | Sell |
44,942
-4,499
| -9% | -$544K | 0.78% | 18 |
|
|
2023
Q1 | $5.74M | Buy |
49,441
+31,551
| +176% | +$3.53M | 0.82% | 16 |
|
|
2022
Q4 | $2.03M | Sell |
17,890
-6,591
| -27% | -$724K | 0.32% | 125 |
|
|
2022
Q3 | $4.23M | Sell |
24,481
-2
| -0% | -$169 | 0.43% | 75 |
|
|
2022
Q2 | $4.13M | Sell |
24,483
-18,765
| -43% | -$1.71M | 0.41% | 81 |
|
|
2022
Q1 | $5.53M | Buy |
43,248
+4,652
| +12% | +$509K | 0.8% | 14 |
|
|
2021
Q4 | $5.18M | Sell |
38,596
-36
| -0.1% | -$5.17K | 0.7% | 21 |
|
|
2021
Q3 | $5.28M | Hold |
38,632
| – | – | 0.78% | 12 |
|
|
2021
Q2 | $4.12M | Hold |
38,632
| – | – | 0.61% | 29 |
|
|
2021
Q1 | $3.47M | Buy |
38,632
+3,136
| +9% | +$294K | 0.58% | 37 |
|
|
2020
Q4 | $3.28M | Buy |
35,496
+4,068
| +13% | +$363K | 0.6% | 43 |
|
|
2020
Q3 | $3.24M | Buy |
31,428
+3,576
| +13% | +$374K | 0.67% | 31 |
|
|
2020
Q2 | $2.82M | Buy |
27,852
+2,664
| +11% | +$238K | 0.66% | 30 |
|
|
2020
Q1 | $1.7M | Sell |
25,188
-26,596
| -51% | -$1.65M | 0.49% | 59 |
|
|
2019
Q4 | $4.13M | Hold |
51,784
| – | – | 0.49% | 58 |
|
|
2019
Q3 | $3.72M | Buy |
51,784
+18,696
| +57% | +$726K | 0.46% | 72 |
|
|
2019
Q2 | $1.24M | Hold |
33,088
| – | – | 0.34% | 109 |
|
|
2019
Q1 | $985K | Buy |
33,088
+1,008
| +3% | +$35.4K | 0.29% | 134 |
|
|
2018
Q4 | $961K | Buy |
32,080
+5,816
| +22% | +$184K | 0.32% | 122 |
|
|
2018
Q3 | $939K | Buy |
26,264
+2,704
| +11% | +$83.8K | 0.25% | 154 |
|
|
2018
Q2 | $559K | Hold |
23,560
| – | – | 0.16% | 216 |
|
|
2018
Q1 | $437K | Hold |
23,560
| – | – | 0.13% | 238 |
|
|
2017
Q4 | $338K | Hold |
23,560
| – | – | 0.11% | 252 |
|
|
2017
Q3 | $288K | Hold |
23,560
| – | – | 0.1% | 265 |
|
|
2017
Q2 | $431K | Buy |
+23,560
| New | +$435K | 0.15% | 211 |
|
Other funds holding DXCM
VCM
VPM
Azzad Asset Management's DXCM Position: Q1 2026 in Review
Azzad Asset Management increased its DexCom (DXCM) stake by 3.1% in Q1 2026, buying an estimated $29.2K and bringing the position to 13,881 shares worth $872K. The position accounts for 0.09% of the portfolio, ranked #243.
Azzad Asset Management first reported a position in DXCM in Q2 2017 and has held it in 35 quarters since. The position peaked at $6.24M in Q1 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.
- Azzad Asset Management held 13,881 shares of DexCom worth $872K as of Q1 2026.
- Azzad Asset Management bought 419 DexCom shares in Q1 2026, an estimated $29.2K.
- DexCom made up 0.09% of Azzad Asset Management's portfolio in Q1 2026, its #243 holding.
- Azzad Asset Management first reported a position in DexCom in Q2 2017 and has held it in 35 quarters since.
- Azzad Asset Management's DexCom position peaked at $6.24M in Q1 2024.
- 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.
Based on Azzad Asset Management's 13F filing for Q1 2026, filed 30 Apr 2026.